| Chen, Jie |
NCT05182463: Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients |
|
|
| Recruiting | 4 | 5000 | RoW | Peginterferon Alfa-2B, Nucleoside Analogs | Third Affiliated Hospital, Sun Yat-Sen University | Hepatitis B, Chronic | 12/26 | 11/29 | | |
NCT05830500: Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma |
|
|
| Recruiting | 4 | 360 | RoW | Anlotinib Hydrochloride Capsule | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Medullary Thyroid Cancer | 06/27 | 12/28 | | |
| Active, not recruiting | 3 | 291 | Europe, Canada, Japan, US, RoW | Selpercatinib, LY3527723, LOXO-292, Cabozantinib, Vandetanib | Loxo Oncology, Inc., Eli Lilly and Company | Medullary Thyroid Cancer | 05/23 | 02/26 | | |
COMPOSE, NCT04919226 / 2021-001086-20: Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - |
|
|
| Recruiting | 3 | 250 | Europe, US, RoW | 177Lu-Edotreotide (Peptide Receptor Radionuclide Therapy) PRRT, 177Lu-DOTATOC 177Lu-Edo, CAPTEM (Capecitabine and Temozolomide), Amino-Acid Solution, Arginine-Lysine Solution, Everolimus, FOLFOX (Folinic acid + Fluorouracil + Oxaliplatin) | ITM Solucin GmbH | Neuroendocrine Tumors | 06/27 | 09/27 | | |
NCT06616532: PM8002 in Combination With Paclitaxel Compared With Chemotherapy as Second-line Treatment in Small Cell Lung Cancer |
|
|
| Recruiting | 3 | 404 | RoW | PM8002, Paclitaxel, Topotecan | Biotheus Inc. | SCLC | 01/27 | 12/28 | | |
| Recruiting | 3 | 120 | Europe, Canada, Japan, US, RoW | Vedolizumab IV, ENTYVIO, KYNTELES, MLN0002 | Takeda, Takeda Development Center Americas, Inc. | Crohn's Disease (CD) | 11/24 | 11/24 | | |
| Active, not recruiting | 3 | 121 | Europe, Canada, Japan, US, RoW | Vedolizumab, MLN0002, ENTYVIO, KYNTELES | Takeda, Takeda Development Center Americas, Inc. | Colitis, Ulcerative | 08/25 | 08/25 | | |
| Recruiting | 3 | 240 | Europe, Canada, Japan, US, RoW | Vedolizumab IV, MLN0002, ENTYVIO, KYNTELES, No Intervention | Takeda, Takeda Development Center Americas, Inc. | Ulcerative Colitis, Crohn's Disease | 08/31 | 08/31 | | |
NCT06398444: A Clinical Study to Evaluate the Safety and Efficacy of Lutetium[177Lu] Oxodotreotide Injection in Patients With Advanced Neuroendocrine Neoplasms |
|
|
| Not yet recruiting | 2/3 | 74 | RoW | Lutetium[177Lu] Oxodotreotide Injection | Sinotau Pharmaceutical Group | Advanced Neuroendocrine Neoplasm | 06/27 | 06/29 | | |
NCT05084677: Toripalimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer |
|
|
| Recruiting | 2 | 96 | RoW | Toripalimab Combined With Concurrent Platinum-based Chemoradiotherapy | Tianjin Medical University Cancer Institute and Hospital | Cervical Cancer | 12/22 | 12/24 | | |
NCT05033132: A Phase II Study of Balstilimab Independently or in Combination With Zalifrelimab in Advanced Cervical Cancer |
|
|
| Withdrawn | 2 | 177 | RoW | Balstilimab, Balstilimab + Zalifrelimab | Agenus Inc., Betta Pharmaceuticals Co., Ltd. | Cervical Cancer | 12/24 | 12/24 | | |
NCT06093438: Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer |
|
|
| Recruiting | 2 | 20 | RoW | Toripalimab | Tianjin Medical University Cancer Institute and Hospital | Cervical Cancer, Induction Chemotherapy, Immunotherapy | 07/25 | 07/26 | | |
NCT04893759: A Study of Pelcitoclax (APG-1252) in Patients With Neuroendocrine Tumors |
|
|
| Recruiting | 1 | 60 | RoW | Pelcitoclax, APG-1252 | Ascentage Pharma Group Inc. | Neuroendocrine Tumors | 06/24 | 06/25 | | |
NCT04741373: Study on Pulmonary Rehabilitation for Stable Chronic Obstructive Pulmonary Disease(COPD) Patients |
|
|
| Recruiting | N/A | 90 | RoW | oral nutritional supplements, rehabilitation exercise, health education | Fudan University | Nutritional Support, Aerobic Exercise, Respiratory Function Tests, Body Composition, Muscle Strength | 06/21 | 09/21 | | |
NCT05176821: Eradication Efficacy and Safety of Two Rescue Treatments for Helicobacter Pylori Infection |
|
|
| Recruiting | N/A | 186 | RoW | esomeprazole plus amoxicillin, HDDT, amoxicillin, furazolidone, bismuth potassium citrate , esomeprazole, FT | Shanghai Zhongshan Hospital | H. Pylori Infection | 12/22 | 12/22 | | |
NCT06461611: Effect of Health Diary on Self-management in Adolescent Patients With Fixed Orthodontic Appliance |
|
|
| Recruiting | N/A | 140 | RoW | Health Diary Program, Traditional Health Education | Wei XIA, PhD | Oral Hygiene, Self-Management | 03/25 | 07/25 | | |
NCT06384001: Meditation for Older Adults With Chronic Low Back Pain |
|
|
| Recruiting | N/A | 66 | US | Active MBM, Sham MBM | Florida State University | Chronic Low Back Pain | 10/25 | 10/25 | | |
| Active, not recruiting | N/A | 51 | RoW | MitraClip procedure | Abbott Medical Devices | Mitral Regurgitation | 05/24 | 05/25 | | |
NCT04995159: Optimized Antiplatelet Therapy in Patients With CHD After Implantation of NeoVasâ„¢ BRS System |
|
|
| Not yet recruiting | N/A | 2150 | RoW | Single anti-platelet therapy, SAPT strategy, Dual anti-platelet therapy, DAPT strategy | Lepu Medical Technology (Beijing) Co., Ltd. | Coronary Heart Disease | 01/26 | 01/28 | | |
NCT05086536: Re-compensation and Its Clinical Characteristics in HBV Decompensated Cirrhosis |
|
|
| Not yet recruiting | N/A | 600 | RoW | no intervention | Beijing Friendship Hospital, Beijing YouAn Hospital, Shandong Provincial Hospital, The Affiliated Hospital of Qingdao University, The First Affiliated Hospital of Shanxi Medical University, Xiangya Hospital of Central South University, The Second Affiliated Hospital of Baotou Medical College | Hepatitis B, Decompensated Cirrhosis | 06/22 | 12/22 | | |
MIES-BCNAT, NCT04661436: Multimodal Imaging Evaluation System of Axillary Lymph Node Staging and Treatment Strategy for Breast Cancer Neoadjuvant Therapy |
|
|
| Not yet recruiting | N/A | 300 | NA | Contrast-Enhanced Ultrasound, Magnetic Resonance Imaging | Sichuan Provincial People's Hospital | Breast Cancer | 12/22 | 12/23 | | |
NCT04830826: A Real-world Study of Adjuvant Therapy in Early Stage NSCLC With EGFR Mutation-Positive in China |
|
|
| Recruiting | N/A | 2000 | RoW | Surgeries | The First Affiliated Hospital of Guangzhou Medical University | NSCLC, Stage I, NSCLC, Stage II, NSCLC, Stage III | 01/24 | 07/24 | | |
